Figure showing steps taken and information on emicizumab in hemophilia A without inhibitors during the HAVEN 3 study. / Emicizumab in hemophilia A without inhibitors.
Figure showing steps taken and information on emicizumab in hemophilia A without inhibitors during the HAVEN 3 study

Emicizumab in hemophilia A without inhibitors.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal